The growing geriatric population as well as increasing prevalence of chronic diseases, increasing significance and knowledge of point-of-care testing, and increasing technical developments in clinical chemistry analyzers are the major reason driving the growth of the demand for clinical chemistry analyzers and reagents.
North America dominated the global market in the year 2019. The growth of the North American market for clinical chemistry analyzers and reagents can be attributed to the rising geriatric population, increasing prevalence of chronic & lifestyle conditions, introducing favorable government policies, increasing healthcare spending, improving healthcare facilities, and the availability of technologically advanced tools. Asia Pacific is predicted to grow at a lucrative CAGR over the study period. Increasing investments along with developing healthcare infrastructure is predicted to maintain high demand in coming years.
The COVID-19 pandemic adversely impacted the companies' sales. Lockdowns led people to postpone undergoing health checks as a consequence of the COVID-19 pandemic, thereby impacting the number of tests being conducted and reagent sales. A revival in testing numbers, however, is seen as countries gradually ease movement restrictions.
Market players are focused on supplying end-users with cost-effective equipment. In clinical laboratories worldwide, automation has become trend. Laboratories have focused on automation to preserve sustainability in order to minimize healthcare costs, as well as maintain healthy profits.
Adroit Market Research study on the global market for surgical clinical chemistry analyzers and reagents offers a holistic view of the industry from 2020 to 2028 as forecast period, including factors such as market drivers, limitations, opportunities, threats and regulatory overview. The market has been analyzed from 2018 to 2028, with a base year estimate of 2019 and a projection from 2020 to 2028. The report covers the current status and potential characteristics of the market at both the global and the country level. Moreover, the report also assesses market competition with Porter's analysis of five strengths and places leading players on the basis of their product range, regional presence, strategic initiatives and overall sales. Prominent players in the global market have been analyzed in depth.
Key vendors in the market include A Mindray Medical International Limited, Thermo Fisher Scientific Inc., Danaher Corporation, Abbott Laboratories, Abbott Laboratories, F.Hoffmann-La Roche Ltd., and many more.
Key Segments of the Global Medical Radiation Shielding Market
Product Overview, 2018-2028 (USD Million)
- Analyzers
- Reagents
- Others
Test Overview, 2018-2028 (USD Million)
- Basic Metabolic Panel (BMP)
- Electrolyte Panel
- Liver Panel
- Lipid Profile
- Renal Profile
- Thyroid Function Panel
- Specialty Chemical Tests
End-use Overview, 2018-2028 (USD Million)
- Hospitals
- Academic Research Centers
- Diagnostic Laboratories
- Others
Regional Overview, 2018-2028 (USD Million)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
- Middle East and Africa
- UAE
- South Africa
- Rest of Middle East and Africa
- South America
- Brazil
- Rest of South America